Picard Medical Inc(PMI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -20.65 | Insider Own | 45.36% | Shs Outstand | 2.1M | Perf Week | -3.71% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 47.06% | Insider Trans | - | Shs Float | 1.3M | Perf Month | 21.49% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -1.5 | Inst Own | 6.5% | Short Float | 5.96% | Perf Quarter | -58.14% |
| Income | -0.03B | P/S | 1.64 | EPS this Y | 77.33% | Inst Trans | 9.84% | Short Ratio | 0.04 | Perf Half Y | -92.33% |
| Sales | 0.01B | P/B | 5.28 | EPS next 5Y | - | ROA | -268.26% | Short Interest | 0.08M | Perf YTD | -94.96% |
| Book/sh | 0.83 | P/C | 257.75 | EPS past 3/5Y | -27.88% - | ROE | - | 52W High | -99.36% ($684.00) | Perf Year | -98.64% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | 6.3% - | ROIC | -1631.29% | 52W Low | 66.29% ($2.65) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 0.82% | Gross Margin | 17.9% | Volatility(W/M) | 19.86% 27.27% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.88 | Sales Y/Y TTM | 41% | Oper. Margin | -248.1% | ATR (14) | 1.42 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.22 | EPS Q/Q | 40.21% | Profit Margin | -444.33% | RSI (14) | 43.64 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.02 | Sales Q/Q | 38.62% | SMA20 | -15.82% ($5.24) | Beta | -1.36 | Target Price | - |
| Payout | - | Debt/Eq | 0.92 | Earnings | 2026/8/20 | SMA50 | -27.71% ($6.1) | Rel Volume | 0.17 | Prev Close | $4.41 |
| Employees | 75 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -103.33% 90.58% | SMA200 | -91.16% ($49.89) | Avg Volume(3M) | 1.86M | Price | $4.41 |
| IPO | 2025/8/29 | Option/Short | No/Yes | Trades | 1040 | Volume | 317,476 | Change | - |
Company
PMI is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🫀 Through its subsidiary SynCardia, the company is a U.S. innovative medical device maker that holds the world's only approved total artificial heart (TAH) technology. It provides a unique life-sustaining solution for end-stage heart failure patients, keeping them alive until they can receive a heart transplant.
Over the past 1 year, on the lower side
99% below its 1-year high.
PMI has weak earning power
Review management risk carefully before investing
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +77.3% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Positive and negative signals are mixed
Tap to view numbers
Holding long would have lost money
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 6.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
GLX 0.00%
HDG 0.00%
HONG 0.00%
ITWO 0.00%
IWC 0.00%It ranks #4 in the industry
Based on market cap of $10M.
PMI $10M PER -
ABT $179B PER 33.4
MDT $117B PER 22.6
SYK $104B PER 28.0
FAQ
What kind of company is PMI?
PMI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of PMI?
The market cap of PMI is approximately $10M, ranking 5,512 within its sector.
What is the 52-week high and low for PMI?
PMI has recorded a 52-week high of $684.00 and a low of $2.65.
